LTF and lung adenocarcinoma: Recently, we have shown that a novel form of rhLf that exhibits a glycosylation profile compatible with the natural human Lf, has selective anticancer effects against human lung adenocarcinoma without cytotoxicity on normal human bronchial epithelial cells [28].